.jpg "BRUCE A. PERKINS, MD MPH FRCP(C) photo")
Professor of Medicine and Clinician-Scientist, University of Toronto
The Sam and Judy Pencer Family Chair in Diabetes and Director of the Diabetes Clinical Research Unit Leadership Sinai Centre for Diabetes, Sinai Health System
University of Toronto
Toronto, Ontario, Canada
Bruce Perkins MD MPH is Professor, Endocrinologist, Epidemiologist and Clinician-Scientist in the Faculty of Medicine and the Institute for Health Policy Management and Evaluation at the University of Toronto. He holds the Sam and Judy Pencer Family Chair in Diabetes Clinical Research and directs the Leadership Sinai Centre for Diabetes. His research platform, research leadership, clinical practice, and advocacy work has focused entirely on strategies to improve the lives of those, like himself, living with type 1 diabetes. Using cohort and trial methods, his research has focused on 1) Early biomarkers and mechanisms of diabetes complications including neuropathy, and 2) complications prevention through artificial pancreas technologies, add-on-to-insulin drug therapies, and, more recently, immunomodulation and cell-based curative therapies.
CC13 - From Awareness to Action: Shining a Light on Presymptomatic Type 1 Diabetes
Friday, November 22, 2024
15:35 - 15:55 AT Time
Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); BMO Bank of Montreal: Grant/Research Support (Ongoing); Dexcom: Advisory Board (Ongoing); Insulet Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Nephris: Advisory Board (Ongoing); Novo Nordisk Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Advisory Board (Ongoing)
Saturday, November 23, 2024
09:40 - 10:55 AT Time
Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); BMO Bank of Montreal: Grant/Research Support (Ongoing); Dexcom: Advisory Board (Ongoing); Insulet Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Nephris: Advisory Board (Ongoing); Novo Nordisk Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Advisory Board (Ongoing)